Abstract:Abstract Background The snoRNA host gene SNHG15 produces a long non-coding RNA (lncRNA) with a short half-life and has been reported to be dysregulated in multiple cancers and has recently been found to be correlated with tumour progression. Therefore, this meta-analysis was performed to evaluate the generalised prognostic role of small nucleolar RNA host gene 15 (SNHG15) in malignancies, based on variable data from different studies. Methods Four public databases were used to identify eligible studies. The association between prognostic indicators and clinical features was extracted and pooled to estimate the hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs). Publication bias was measured using Begg’s test and Egger’s test, and the stability of pooled results were measured using sensitivity analysis. Additionally, an online database based on The Cancer Genome Atlas (TCGA) was screened to further validate our results. Ultimately, we predicted the molecular regulation of SNHG15 based on the public databases. Results In total, 11 studies including 1087 patients were ultimately enrolled in our meta-analysis. We found that SNHG15 overexpression was associated with worse overall survival (OS) and disease-free survival (DFS), and this was validated in the Gene Expression Profiling Interactive Analysis (GEPIA) cohort. Moreover, increased SNHG15 expression suggested advanced TNM stage and LNM, but was not associated with age, gender, or tumour size. No publication bias or instability of the results was observed. SNHG15 was significantly upregulated in seven cancers and elevated expression of SNHG15 indicated shorter OS and DFS in five malignancies based on the validation using the GEPIA cohort. Further functional prediction indicated that SNHG15 may participate in some cancer-related pathways. Conclusions Upregulation of lncRNA SNHG15 was notably associated with worse prognosis and clinical features, suggesting that SNHG15 might serve as a novel prognostic factor in various cancers.

SNHG20: A Vital Lncrna in Multiple Human Cancers

Long noncoding RNA SNHG17: a novel molecule in human cancers

SNHG7: A Novel Vital Oncogenic Lncrna in Human Cancers.

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers

Increased Long Noncoding RNA SNHG20 Predicts Poor Prognosis in Colorectal Cancer.

Long non-coding SNHG1 in cancer

Ott_a_267140 7699..7717

&Lt;p>long Non-Coding Small Nucleolar RNA Host Genes (snhgs) in Endocrine-Related Cancers</p>

Cmar_a_208054 5961..5969

Small nucleolar RNA host gene 3 functions as a novel biomarker in liver cancer and other tumour progression

The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes

Prognostic Value of Long Non-Coding RNA SNHG20 in Cancer

Long Non-Coding Small Nucleolar RNA Host Genes (SNHGs) in Endocrine-Related Cancers

Long non-coding RNA SNHG15 in various cancers: a meta and bioinformatic analysis

A novel regulator in cancer initiation and progression: long noncoding RNA SHNG9

DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA

Prognostic Value of Long Non-Coding RNA SNHG20 in Cancer A Meta-Analysis

The Long Noncoding RNA SNHG1 Regulates Colorectal Cancer Cell Growth Through Interactions with EZH2 and Mir-154-5p

Up-regulation of Long Non-Coding RNA SNHG20 Promotes Ovarian Cancer Progression Via Wnt/β-catenin Signaling

Long Noncoding RNA Small Nucleolar Host Gene: A Potential Therapeutic Target in Urological Cancers

Long Non-Coding RNA SNHG20 Promotes the Tumorigenesis of Oral Squamous Cell Carcinoma Via Targeting Mir-197/Lin28 Axis